Max Bartlett

Cytomyx Holdings Plc provided drug discovery products and services. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom.

York Pharma Plc activity is acquiring, developing and commercialising prescription dermatological products. It focuses on a dermatological product called abafungin, a topical therapy intended for the treatment of fungal infections and some mixed microbial infections. The Group's product will be marketed under the trade mark Abasol. The Group's other product brands are Sabarep and Vampex. The Group operates in the United Kingdom, Japan and Germany.

Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics.

VivoMedica Plc engages in identifying and exploiting product development opportunities in the medical technology sector. The company was founded September 6, 2000 and is headquartered in Bury, the United Kingdom.

Cytomyx Ltd. provides ion channel cell lines and drug discovery services. The company develops and markets products and services to customers in the pharmaceutical, diagnostics and academic research markets. It is a subsidiary of Celliance Ltd. Cytomyx was founded in 1996 and is headquartered in Cambridge, UK

Part of Deloitte LLP (New York), Deloitte, Haskins & Sells LLP provides accounting services. The company is based in Mumbai, India.

Hartest Holdings Ltd. manufactures, sells and distributes precision instruments used in testing, measurement, performance improvement and research. The company specializes in delivering well recognized product and service brands into niche markets both at home and abroad. It operates under two divisions: Instrumentation and Medical Services. The Instrumentation division manufactures, sells and distributes a range of specialist instruments and supplies for use in testing, measurement, performance improvement, and research around the world. The brands covered by this division are Sheen Instruments-surface coatings, Wallace Instruments-rubber testing, ASL-temperature measurement, Tinsley Ophthalmic and Henson-ophthalmic testing, Tinsley Precision-underwater cable fault location and electrical impulse testing, Carnation Designs-power management systems for specialist vehicles and Agar Scientific-equipment and consumables for use with electron microscopes. The above operations of Sheen, Wallace, ASL, Tinsley Ophthalmic and Tinsley Precision operate jointly within one company, Hartest Precision Instruments Ltd. The Medical Services division trades under the names of Qados and Cross Technologies, acting as a distributor in the business areas of specialist medical and healthcare equipment, in both the public and private sectors. This division mainly operates in United Kingdom and Ireland. In addition to the sale of medical equipment, the division also has an active service and consumables operation, and is engaged in the distribution of radiopharmaceuticals. The company was founded on December 12, 1998 and is headquartered in Sandhurst, the United Kingdom.

Acaris Healthcare Solutions Plc developed disposable consumer devices to detect house dust mite allergens. The firm provided precuts for the healthcare and industrial sectors. The company was founded in September 1999 by Ramin Pirzad and Antony Cooke and headquartered in Cambridge, GB.

Team Consulting Ltd. provides product development consulting services. It assists its clients at every stage of the product development process, which cover: product strategy, due diligence, user research, industrial design, risk analysis, product engineering, and industrialization. The company was founded by Andy Fry, Perran Newman, Alan Goodman, John Targell and Peter Sharpe on November 11, 1986 and is headquartered in Cambridge, the United Kingdom.